<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26086" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Obstructive Uropathy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rishor-Olney</surname>
            <given-names>Colton R.</given-names>
          </name>
          <aff>Conemaugh Memorial Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hinson</surname>
            <given-names>Melissa R.</given-names>
          </name>
          <aff>Conemaugh Memorial</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Colton Rishor-Olney declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Melissa Hinson declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>22</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26086.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Obstructive uropathy is a hindrance to normal urinary flow that can be caused by a variety of structural and functional etiologies. This is a common and potentially serious condition that affects people across all ages and walks of life. To avoid the morbidity and mortality associated with this condition, it must be promptly diagnosed and treated. This activity reviews the evaluation and management of patients with obstructive uropathy. It represents a common presentation affecting multiple medical specialties and highlights the role of the interprofessional team in early identification and improved care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of obstructive uropathy related medical conditions and emergencies.</p></list-item><list-item><p>Review the appropriate evaluation of obstructive uropathy.</p></list-item><list-item><p>List the management options available for obstructive uropathy.</p></list-item><list-item><p>Discuss interprofessional team strategies for improving care coordination of obstructive uropathy in an effort to improve timely identification and patient outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26086&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26086">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-26086.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Obstructive uropathy is a disorder of the urinary tract that occurs due to obstructed urinary flow and can be either structural or functional. The back-up of urine into the unilateral or bilateral kidneys, depending on the location of the obstruction, causes hydronephrosis. The obstruction can present as a motley of symptoms but will typically involve a combination of difficultly initiating micturition, acute urinary retention, or lower abdominal discomfort and distention. The condition can be acute or chronic. It can occur across all age groups and demographics. This article will provide a detailed review of obstructive uropathy.</p>
      </sec>
      <sec id="article-26086.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>There are a significant number of potential causes of obstructive uropathy, and these vary widely. However, the most frequently diagnosed cause is benign prostatic hypertrophy or hyperplasia.&#x000a0; Although not particularly common, other potential causes include constipation, urethral strictures, phimosis or paraphimosis, prostatic adenocarcinoma, retroperitoneal adenopathy, colonic endometriosis, ureterocele, urolithiasis, and neuropathic bladder dysfunction, parasitic obstructions, bladder endometriosis, and urate nephrolithiasis.<xref ref-type="bibr" rid="article-26086.r1">[1]</xref><xref ref-type="bibr" rid="article-26086.r2">[2]</xref><xref ref-type="bibr" rid="article-26086.r3">[3]</xref><xref ref-type="bibr" rid="article-26086.r4">[4]</xref><xref ref-type="bibr" rid="article-26086.r5">[5]</xref><xref ref-type="bibr" rid="article-26086.r6">[6]</xref>&#x000a0;The history and physical examinations are key in the diagnosis of the underlying cause.&#x000a0; Obstructive uropathy can also present in the neonatal period, prompting evaluation for genitourinary tract dilatation and vesicoureteral reflux and highlighting the importance of intrauterine fetal anatomy ultrasounds.<xref ref-type="bibr" rid="article-26086.r7">[7]</xref></p>
      </sec>
      <sec id="article-26086.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Urinary obstruction affects all age groups, but the majority of cases present in the bimodal distribution in infants and the elderly. Congenital genitourinary tract abnormalities (e.g., posterior urethral valves) present in childhood as urinary obstruction, producing an estimate of approximately 4% of the total cases.<xref ref-type="bibr" rid="article-26086.r8">[8]</xref>&#x000a0;The largest group is made up of people over 60 and more frequently males due to the anatomic presence of prostate (benign prostatic hyperplasia and cancers). Symptoms of urinary retention occur in up to 1% to 2% of men with BPH per year.<xref ref-type="bibr" rid="article-26086.r9">[9]</xref>&#x000a0;Obstructive uropathy is significantly less common in females.</p>
      </sec>
      <sec id="article-26086.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>When there is a restriction to the normal flow of urine through the urinary tract, there will be a back pressure of urine into the collecting system of the kidneys. In time, this may produce dilatation within the tract, and as the kidneys filtration system becomes affected, it becomes the primary reason for the development of obstructive nephropathy. The mechanism of nephropathy, in this case, involves many factors, including local ischemia due to distention and increased intratubular pressures.&#x000a0; In a partial obstruction, angiotensin and AT1-receptor appear to be upregulated, increasing ureteral peristalsis to help relieve the obstruction.<xref ref-type="bibr" rid="article-26086.r10">[10]</xref></p>
        <p>While peristaltic function may be of benefit in a partial obstruction, it is likely to cause increased distention and intraluminal pressures when the obstruction is complete. Rat models have also demonstrated influence from the renin-angiotensin-aldosterone axis, and TGF-beta1 expression was markedly increased in hydronephrotic kidneys,&#x000a0;which may occur in humans as well, but further studies are needed.<xref ref-type="bibr" rid="article-26086.r11">[11]</xref> These factors may lead to irreversible damage to the kidney, but it is difficult to predict the time and rate at which this will occur. This highlights the importance of early identification and treatment of the underlying obstruction.</p>
      </sec>
      <sec id="article-26086.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Obstructive uropathy may lead to a reduced glomerular number, glomerular hyalinization, cortical cysts, and interstitial inflammation within the kidney.<xref ref-type="bibr" rid="article-26086.r12">[12]</xref>&#x000a0;It is believed these histopathological changes are secondary to an inflammatory process.<xref ref-type="bibr" rid="article-26086.r13">[13]</xref></p>
      </sec>
      <sec id="article-26086.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The severity of symptoms and likely even the number of symptoms present are influenced by the degree, location, and time from the onset of the obstruction. The presence of pain is common in urinary tract obstructions. Patients may present with abdominal and/or flank pain. The location, quality, severity, and modifying factors of the discomfort may help to aid in determining the location and underlying cause. For example, dull flank pain with sharp radiation into the lower quadrant or groin may suggest ureterolithiasis as the underlying cause of obstruction.</p>
        <p>Nocturia, dysuria, urinary urgency or frequency, and decreased force of urinary stream should suggest benign prostatic hypertrophy/hyperplasia or prostatic adenocarcinoma. Fever should increase your concern for concomitant urinary tract infection and, possibly, septicemia. Prostatic malignancy should be considered in the presence of recent unintentional weight loss, night sweats, and hematuria with a nodular prostate on examination. Radiation and other treatments for prior malignancies can increase scarring in the GU tract and produce obstruction. Gastrointestinal symptoms of constipation, nausea, vomiting, and diarrhea may aid in diagnosing fecal impaction, bowel obstruction, or a colonic mass as contributing factors to the urinary tract obstructions. Recent surgeries (e.g., appendectomy, hysterectomy) can suggest ureteral injury. As evidenced above, providers must perform a complete history and a thorough review of systems.</p>
        <p>A complete examination should be performed, focusing on the abdomen and genitalia. The presence of a distended bladder should direct the clinician to the possibility of urinary retention. A digital rectal examination may reveal prostatic enlargement or fecal impaction. An assessment of strength, sensation, reflexes, and muscle tone can be informative. A thorough history and physical examination will often point towards the underlying etiology.</p>
      </sec>
      <sec id="article-26086.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>A basic metabolic panel should be performed in most patients with evidence of obstructive uropathy, with a specific focus on the patient's renal function. Urinalysis should be performed to rule out urinary tract infection. Urine protein-to-creatinine ratio and urine electrolytes may be beneficial for guiding further care. A bedside ultrasound should be performed to quickly assess the bladder volume and the severity of hydronephrosis. Ultrasound is the most readily available and least invasive test. A comprehensive ultrasound can also be performed for further assessment. The next radiographic test to be considered for most providers would be a CT of the abdomen and pelvis, especially if there is a concern for intra-abdominal pathologies, such as tumors. Additional testing to be considered in specific circumstances would be intravenous pyelogram, voiding cystourethrogram, and renal nuclear scans.&#x000a0; MRI can also be considered.</p>
      </sec>
      <sec id="article-26086.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Electrolyte abnormalities should be corrected, as indicated. If renal function is significantly worse from baseline, or there are significant electrolyte abnormalities, hospital admission and urgent nephrology consultation may be warranted. Urinalysis is likely to be performed to rule out infection, and antibiotics should be prescribed as indicated. Urine samples are often also sent for culture.</p>
        <p>The treatment of obstructive uropathy is based around promptly addressing the obstructive process. Bladder volume measurements can help to guide further therapies from this point. A Foley catheter is likely to be attempted, particularly if the obstruction is due to the most frequent etiology, benign prostatic hypertrophy, or hyperplasia.<xref ref-type="bibr" rid="article-26086.r14">[14]</xref>&#x000a0;The initial attempt usually occurs with a 16- or 18-Fr Foley. The presence of obstruction may prevent the initial success of urethral catheterization and may require higher-level interventions. The most typical next step would be a trial of urethral catheterization using a Coud&#x000e9; tip Foley, but more significant interventions may be required and are addressed in other articles.<xref ref-type="bibr" rid="article-26086.r15">[15]</xref><xref ref-type="bibr" rid="article-26086.r16">[16]</xref><xref ref-type="bibr" rid="article-26086.r17">[17]</xref>&#x000a0;</p>
        <p>While unlikely, suprapubic catheterization or cystostomy may be required for cases when urethral catheterization is not feasible. The duration of time the Foley should be in place is based on a combination of the initial bladder volume and post-catheterization residual. This decision often occurs in conjunction with a urologist. Outpatient follow-up with urology should be arranged as they will play a significant role in determining the need for and guiding long-term therapies. The Foley catheter will be removed at the discretion of the urologist at follow-up. Infrequently, individuals may fail the trial without a catheter, resulting in the replacement of the catheter. At this point, additional interventions may be indicated, including ureteral stents, drains, or placement of nephrostomy tubes. There may be a potential benefit of more invasive procedures for the management of obstructions that fail more conservative management, and these include prostate artery embolization.<xref ref-type="bibr" rid="article-26086.r18">[18]</xref></p>
        <p>There are certain cases where medication therapies may be pursued. Medications that inhibit alpha-1-adrenergic receptors (e.g., tamsulosin, terazosin), which result in relaxation of the smooth muscle within the bladder neck and prostate, have been indicated to improve symptoms of urinary obstructive secondary to BPH. Tamsulosin demonstrated having a positive effect for moderate to severe obstructive symptoms due to benign prostatic hypertrophy.<xref ref-type="bibr" rid="article-26086.r19">[19]</xref>&#x000a0;While orthostasis is a commonly cited concern with the use of this medication, several studies have suggested the absence of any significant side effects.<xref ref-type="bibr" rid="article-26086.r20">[20]</xref><xref ref-type="bibr" rid="article-26086.r21">[21]</xref>&#x000a0;Bicalutamide and leuprolide, which act via antiandrogen and luteinizing hormone agonism, respectively, may help to relieve obstruction by shrinking the prostate.<xref ref-type="bibr" rid="article-26086.r22">[22]</xref><xref ref-type="bibr" rid="article-26086.r23">[23]</xref><xref ref-type="bibr" rid="article-26086.r24">[24]</xref>&#x000a0;</p>
        <p>Finasteride and dutasteride are each FDA-approved for the treatment of BPH. These medications act by inhibiting the 5-alpha-reductase enzyme, blocking the conversion of&#x000a0;testosterone to dihydrotestosterone, and reducing prostate size.<xref ref-type="bibr" rid="article-26086.r25">[25]</xref>&#x000a0;Several of these medical therapies may be combined and are likely to produce a synergistic effect.</p>
        <p>Management of nephropathy due to obstruction also begins with relieving the urinary tract obstruction, but is an entire topic in itself and will not be discussed further here.</p>
      </sec>
      <sec id="article-26086.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnoses are broad and dependent on location, timing, and risk factors. A detailed history and thorough physical examination allow for inclusion, or exclusion, of differentials. The presence of urinary retention may be secondary to an obstruction, infection, medication side effect, neurogenic, secondary to spinal cord impingement, detrusor muscle dysfunction, and may also be acute or chronic in nature.<xref ref-type="bibr" rid="article-26086.r26">[26]</xref>&#x000a0;</p>
        <p>Fever or other constitutional symptoms can point towards infectious etiologies, such as pyelonephritis or spinal epidural abscess. Unilateral flank pain and known renal stone disease could indicate obstruction from ureterolithiasis. Prior urologic instrumentation procedures should lead the provider to consider urethral strictures or blood clots as a cause of obstruction. The presence of neurologic deficits should prompt evaluation for stroke or spinal cord diseases.</p>
        <p>History of intravenous drug use can suggest epidural abscess or discitis. The presence of malignancy raises suspicion for spinal cord or vertebral metastases. Aortic aneurysm or dissection should be considered as a cause of flank pain in a patient with a history of hypertension and smoking. Constipation or the presence of a fecal impaction could produce obstruction in the urinary tract.&#x000a0; Medication changes or recent anesthetic events may lead to symptoms of retention. As with all patient presentations, history and physical examination will guide your differential diagnoses and diagnostic workups.</p>
      </sec>
      <sec id="article-26086.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Prognosis depends on the underlying etiology of the obstruction.&#x000a0; An acute urologic obstruction is more likely to be reversible and less likely to produce damage to the kidney filtration system or other functions. However, chronic obstruction produces worse long-term effects on renal function. The development of chronic renal problems is less likely if only one of the kidneys is affected by the initial obstructive process. Although uncommon after the resolution of acute obstruction, if renal dysfunction persists or worsens, long term outlook could include the need for hemodialysis or renal transplant. The overall prognosis worsens if concomitant UTIs remain untreated.</p>
      </sec>
      <sec id="article-26086.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Complications are often the result of the underlying cause, and management of these vary on a case-by-case basis. However, as mentioned above, an obstruction can lead to permanent damage and possibly failure of the kidneys. Again, while this is less likely to occur during an acute obstruction, it remains possible, and the likelihood increases if the obstruction is chronic. It is especially important to recognize signs of obstruction in fetuses and neonates, as it is the leading cause of renal failure and would cause significant long-term morbidity and mortality for the child.<xref ref-type="bibr" rid="article-26086.r7">[7]</xref>&#x000a0;For children with chronic renal failure, obstructive uropathy was felt to be accountable for 16.5% of all pediatric renal transplants.<xref ref-type="bibr" rid="article-26086.r27">[27]</xref>&#x000a0;</p>
        <p>The identification of these issues in utero can improve the overall outlook for these children, highlighting the importance of the anatomic fetal ultrasound.<xref ref-type="bibr" rid="article-26086.r28">[28]</xref>&#x000a0;Obstructive uropathy has been suggested to increase the likelihood of urinary tract infections, but UTI may also be the first sign of obstruction.<xref ref-type="bibr" rid="article-26086.r29">[29]</xref>&#x000a0;</p>
        <p>Microscopic hematuria is common following urethral catheterization, but more significant bleeding can occur, and these would require intervention (possibly continuous bladder irrigation through a 3-way Foley). Transient hypotension and bradycardia may occur after placement of the Foley but generally resolves with observation alone.</p>
        <p>Previously, it was thought that the bladder should be drained more gradually due to hypotension, but more recent studies have demonstrated no significant difference in outcomes between rapid and gradual drainage.<xref ref-type="bibr" rid="article-26086.r30">[30]</xref>&#x000a0; Postobstructive diuresis, which is addressed further in a separate article,&#x000a0;may occur, and these patients may benefit from hospital observation for close monitoring of vital signs and electrolytes.<xref ref-type="bibr" rid="article-26086.r31">[31]</xref></p>
      </sec>
      <sec id="article-26086.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>A consultation with urology will be at the foundation of most newly diagnosed obstructive uropathies, as GU tract obstruction is a primary urologic issue. Additional consultations will vary based on the underlying etiology of the obstruction but may range from urology alone to a multidisciplinary approach, such as with a newly diagnosed mass as the source of obstruction.</p>
      </sec>
      <sec id="article-26086.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>The patient with obstructive uropathy should be educated on catheter care, including how to properly secure the catheter, and on monitoring urine output. Advise the patient regarding potential reasons to seek immediate care (e.g., fever, blocked Foley, gross hematuria, severe pain). They should be counseled on the importance of adherence to recommended follow up plans, both for management of underlying conditions and to prevent recurrent obstructions. If medications are being prescribed, it is important to inform the patient of potential side effects.</p>
      </sec>
      <sec id="article-26086.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Obstructive uropathy can affect an individual in any age group and from an extremely wide variety of demographics. The management of the condition producing the obstruction does not stop at the first visit to a clinic, or in the emergency department, and it is likely this may require a multidisciplinary approach. The first example includes an ovarian mass, which may require urology, gynecology, oncology (or gynecological oncology), to list a few. A second example could be for a gastrointestinal malignancy producing urologic obstruction, which may require urology, gastroenterology, oncology, and general surgery, among others. A diagnosis of posterior urethral valves producing obstruction in an infant male would create a need for an entirely different team of specialists.</p>
        <p>If the underlying etiology of the obstruction is likely to cause issues with a patient's mental health, as with a newly diagnosed cancer, we should help to arrange psychological therapies. The point being that coordination with multiple specialists takes time and can be frustrating, but our focus should remain on the patient and helping them to cope with their new diagnosis. (Level IV)</p>
      </sec>
      <sec id="article-26086.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26086&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26086">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/kidney-health/obstructive-uropathy/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=26086">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26086/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26086">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-26086.s17">
        <title>References</title>
        <ref id="article-26086.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yap</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Salifu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sanusi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Joseph</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mallappallil</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Atypical Causes of Urinary Tract Obstruction.</article-title>
            <source>Case Rep Nephrol</source>
            <year>2019</year>
            <volume>2019</volume>
            <fpage>4903693</fpage>
            <pub-id pub-id-type="pmid">30937201</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grant</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bayne</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Ureterocele Causing Bladder Outlet Obstruction.</article-title>
            <source>J Pediatr</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>198</volume>
            <fpage>319</fpage>
            <pub-id pub-id-type="pmid">29685621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heyns</surname>
                <given-names>CF</given-names>
              </name>
            </person-group>
            <article-title>Urinary tract infection associated with conditions causing urinary tract obstruction and stasis, excluding urolithiasis and neuropathic bladder.</article-title>
            <source>World J Urol</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>77</fpage>
            <page-range>77-83</page-range>
            <pub-id pub-id-type="pmid">21720861</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sundaram</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Abraham</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Shantha</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Mathew</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Obstructive uropathy from Ascaris lumbricoides.</article-title>
            <source>Kidney Int</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>75</volume>
            <issue>11</issue>
            <fpage>1242</fpage>
            <pub-id pub-id-type="pmid">19444277</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gyang</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Gomez</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Lamvu</surname>
                <given-names>GM</given-names>
              </name>
            </person-group>
            <article-title>Endometriosis of the bladder as a cause of obstructive uropathy.</article-title>
            <source>JSLS</source>
            <year>2014</year>
            <season>Apr-Jun</season>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>357</fpage>
            <page-range>357-60</page-range>
            <pub-id pub-id-type="pmid">24960507</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ganguli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chalokia</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Kaur</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Obstructive Uropathy as an Initial Presentation of Primary Myelofibrosis: Case Report and Review of Literature.</article-title>
            <source>Indian J Hematol Blood Transfus</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>32</volume>
            <issue>Suppl 1</issue>
            <fpage>117</fpage>
            <page-range>117-20</page-range>
            <pub-id pub-id-type="pmid">27408371</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McLean</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Gearhart</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Jeffs</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Neonatal obstructive uropathy.</article-title>
            <source>Pediatr Nephrol</source>
            <year>1988</year>
            <month>Jan</month>
            <volume>2</volume>
            <issue>1</issue>
            <fpage>48</fpage>
            <page-range>48-55</page-range>
            <pub-id pub-id-type="pmid">3153001</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El Imam</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Omran</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nugud</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Elsabiq</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saad</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Taha</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Obstructive uropathy in Sudanese patients.</article-title>
            <source>Saudi J Kidney Dis Transpl</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>415</fpage>
            <page-range>415-9</page-range>
            <pub-id pub-id-type="pmid">16970266</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McNicholas</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kirby</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Benign prostatic hyperplasia and male lower urinary tract symptoms (LUTS).</article-title>
            <source>BMJ Clin Evid</source>
            <year>2011</year>
            <month>Aug</month>
            <day>26</day>
            <volume>2011</volume>
            <pub-id pub-id-type="pmid">21871136</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matsusaka</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Miyazaki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ichikawa</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>The renin angiotensin system and kidney development.</article-title>
            <source>Annu Rev Physiol</source>
            <year>2002</year>
            <volume>64</volume>
            <fpage>551</fpage>
            <page-range>551-61</page-range>
            <pub-id pub-id-type="pmid">11826279</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seseke</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Thelen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hemmerlein</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kliese</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Z&#x000f6;ller</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ringert</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Histologic and molecular evidence of obstructive uropathy in rats with hereditary congenital hydronephrosis.</article-title>
            <source>Urol Res</source>
            <year>2000</year>
            <month>Apr</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>104</fpage>
            <page-range>104-9</page-range>
            <pub-id pub-id-type="pmid">10850632</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elder</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Stansbrey</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dahms</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Selzman</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Renal histological changes secondary to ureteropelvic junction obstruction.</article-title>
            <source>J Urol</source>
            <year>1995</year>
            <month>Aug</month>
            <volume>154</volume>
            <issue>2 Pt 2</issue>
            <fpage>719</fpage>
            <page-range>719-22</page-range>
            <pub-id pub-id-type="pmid">7609162</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steinhardt</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Ramon</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Salinas-Madrigal</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Glomerulosclerosis in obstructive uropathy.</article-title>
            <source>J Urol</source>
            <year>1988</year>
            <month>Nov</month>
            <volume>140</volume>
            <issue>5 Pt 2</issue>
            <fpage>1316</fpage>
            <page-range>1316-8</page-range>
            <pub-id pub-id-type="pmid">3184311</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manjunath</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Hofer</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Urologic Emergencies.</article-title>
            <source>Med Clin North Am</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>102</volume>
            <issue>2</issue>
            <fpage>373</fpage>
            <page-range>373-385</page-range>
            <pub-id pub-id-type="pmid">29406065</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Willette</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Coffield</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Current trends in the management of difficult urinary catheterizations.</article-title>
            <source>West J Emerg Med</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>13</volume>
            <issue>6</issue>
            <fpage>472</fpage>
            <page-range>472-8</page-range>
            <pub-id pub-id-type="pmid">23359117</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Villanueva</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hemstreet</surname>
                <given-names>GP</given-names>
              </name>
            </person-group>
            <article-title>Difficult male urethral catheterization: a review of different approaches.</article-title>
            <source>Int Braz J Urol</source>
            <year>2008</year>
            <season>Jul-Aug</season>
            <volume>34</volume>
            <issue>4</issue>
            <fpage>401</fpage>
            <page-range>401-11; discussion 412</page-range>
            <pub-id pub-id-type="pmid">18778491</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chiou</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Aggarwal</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>[Not Available].</article-title>
            <source>Can Urol Assoc J</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>189</fpage>
            <page-range>189-192</page-range>
            <pub-id pub-id-type="pmid">19543460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kenny</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Pellerin</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Amouyal</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Desgranchamps</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>M&#x000e9;ria</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>De Gouvello</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dariane</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>D&#x000e9;an</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pereira</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Thiounn</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sapoval</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Prostate Artery Embolization in Patients With Acute Urinary Retention.</article-title>
            <source>Am J Med</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>132</volume>
            <issue>11</issue>
            <fpage>e786</fpage>
            <page-range>e786-e790</page-range>
            <pub-id pub-id-type="pmid">31103644</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dunn</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Matheson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Faulds</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms.</article-title>
            <source>Drugs Aging</source>
            <year>2002</year>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>135</fpage>
            <page-range>135-61</page-range>
            <pub-id pub-id-type="pmid">11950378</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Narayan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tunuguntla</surname>
                <given-names>HS</given-names>
              </name>
            </person-group>
            <article-title>Long-term efficacy and safety of tamsulosin for benign prostatic hyperplasia.</article-title>
            <source>Rev Urol</source>
            <year>2005</year>
            <volume>7 Suppl 4</volume>
            <issue>Suppl 4</issue>
            <fpage>S42</fpage>
            <page-range>S42-8</page-range>
            <pub-id pub-id-type="pmid">16986054</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lowe</surname>
                <given-names>FC</given-names>
              </name>
            </person-group>
            <article-title>Summary of clinical experiences with tamsulosin for the treatment of benign prostatic hyperplasia.</article-title>
            <source>Rev Urol</source>
            <year>2005</year>
            <volume>7 Suppl 4</volume>
            <issue>Suppl 4</issue>
            <fpage>S13</fpage>
            <page-range>S13-21</page-range>
            <pub-id pub-id-type="pmid">16986050</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eri</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Tveter</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <article-title>Effects of bicalutamide and leuprolide on prostate-specific antigen (PSA), acid phosphatase (ACP) and prostatic acid phosphatase (PAP) in men with benign prostatic hyperplasia (BPH).</article-title>
            <source>Prostate Cancer Prostatic Dis</source>
            <year>2001</year>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>173</fpage>
            <page-range>173-177</page-range>
            <pub-id pub-id-type="pmid">12497037</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eri</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Tveter</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <article-title>A prospective, placebo-controlled study of the antiandrogen Casodex as treatment for patients with benign prostatic hyperplasia.</article-title>
            <source>J Urol</source>
            <year>1993</year>
            <month>Jul</month>
            <volume>150</volume>
            <issue>1</issue>
            <fpage>90</fpage>
            <page-range>90-4</page-range>
            <pub-id pub-id-type="pmid">7685428</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strutt</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Blackledge</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Kennealey</surname>
                <given-names>GT</given-names>
              </name>
            </person-group>
            <article-title>Re: A prospective, placebo-controlled study of the antiandrogen Casodex as treatment for patients with benign prostatic hyperplasia.</article-title>
            <source>J Urol</source>
            <year>1994</year>
            <month>May</month>
            <volume>151</volume>
            <issue>5</issue>
            <fpage>1355</fpage>
            <page-range>1355-6</page-range>
            <pub-id pub-id-type="pmid">7512665</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tacklind</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fink</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Macdonald</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rutks</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Wilt</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Finasteride for benign prostatic hyperplasia.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2010</year>
            <month>Oct</month>
            <day>06</day>
            <volume>2010</volume>
            <issue>10</issue>
            <fpage>CD006015</fpage>
            <pub-id pub-id-type="pmid">20927745</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r26">
          <label>26</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Dougherty</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Leslie</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Aeddula</surname>
                <given-names>NR</given-names>
              </name>
            </person-group>
            <chapter-title>Male Urinary Retention: Acute and Chronic</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>4</month>
            <day>20</day>
            <pub-id pub-id-type="pmid">30860734</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roth</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Koo</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Spottswood</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Obstructive uropathy: an important cause of chronic renal failure in children.</article-title>
            <source>Clin Pediatr (Phila)</source>
            <year>2002</year>
            <month>Jun</month>
            <volume>41</volume>
            <issue>5</issue>
            <fpage>309</fpage>
            <page-range>309-14</page-range>
            <pub-id pub-id-type="pmid">12086196</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arthur</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Irving</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Watters</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Bilateral fetal uropathy: what is the outlook?</article-title>
            <source>BMJ</source>
            <year>1989</year>
            <month>May</month>
            <day>27</day>
            <volume>298</volume>
            <issue>6685</issue>
            <fpage>1419</fpage>
            <page-range>1419-20</page-range>
            <pub-id pub-id-type="pmid">2502276</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stein</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dogan</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Hoebeke</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ko&#x0010d;vara</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nijman</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Radmayr</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tekg&#x000fc;l</surname>
                <given-names>S</given-names>
              </name>
              <collab>European Association of Urology</collab>
              <collab>European Society for Pediatric Urology</collab>
            </person-group>
            <article-title>Urinary tract infections in children: EAU/ESPU guidelines.</article-title>
            <source>Eur Urol</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>67</volume>
            <issue>3</issue>
            <fpage>546</fpage>
            <page-range>546-58</page-range>
            <pub-id pub-id-type="pmid">25477258</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Etafy</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Saleh</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Ortiz-Vanderdys</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hamada</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Refaat</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Aal</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Deif</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gawish</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Abdellatif</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Gadalla</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Rapid versus gradual bladder decompression in acute urinary retention.</article-title>
            <source>Urol Ann</source>
            <year>2017</year>
            <season>Oct-Dec</season>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>339</fpage>
            <page-range>339-342</page-range>
            <pub-id pub-id-type="pmid">29118535</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26086.r31">
          <label>31</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Leslie</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Sajjad</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <chapter-title>Postobstructive Diuresis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>2</month>
            <day>16</day>
            <pub-id pub-id-type="pmid">29083564</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
